The Swiss Medical Board has ceased its activities.

The website remains available but is no longer updated after June 30, 2022.

DE | EN | FR

Alzheimer’s disease: combination therapy not recommended

[Translate to English:]

[Translate to English:]

This HTA report examines the evidence for the effectiveness, safety and cost/benefit ratio of combination therapy by comparison with monotherapy for patients with moderately severe to severe Alzheimer’s disease. It did not make comparisons between monotherapy and no treatment.